NCT00522678View on ClinicalTrials.gov

Repeat Dose GW685698X With Magnesium Stearate, Excipient Bridging Study, In Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

February 15, 2007

Primary Completion Date

April 25, 2007

Study Completion Date

April 25, 2007

Conditions
Asthma
Interventions
DRUG

GW685698X

Subject will receive GW685698X containing magnesium stearate with unit dose strength of 400, 600 and 800 mcg inhaled via DISKUS

DRUG

Placebo

Subject will receive Placebo matching GW685698X via DISKUS.

Trial Locations (1)

3004

GSK Investigational Site, Melbourne

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00522678 - Repeat Dose GW685698X With Magnesium Stearate, Excipient Bridging Study, In Healthy Volunteers | Biotech Hunter | Biotech Hunter